GlassScriptPhysician profile
Elizabeth Ann Gaffney
NPI 1912647983
$4,507.96
in general payments reported to CMS, 2019-2025
19 companies · $3,828 in 2025
The $3,828 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $680 · 2025: $3,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,262 · Education: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,262.47 |
| Education | $245.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $763.85 | 2024-2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $716.86 | 2024-2025 | Zoryve |
| Abbvie INC. | $478.22 | 2024-2025 | |
| Galderma Laboratories, L.P. | $344.47 | 2025 | Nemluvio |
| Amgen INC. | $282.46 | 2025 | Otezla |
| Ucb, INC. | $246.13 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $235.29 | 2025 | Dupixent |
| Botanix Sb INC | $234.78 | 2025 | Sofdra |
| Sun Pharmaceutical Industries INC. | $185.81 | 2024-2025 | |
| Genzyme Corporation | $177.61 | 2024-2025 | |
| Incyte Corporation | $155.95 | 2024-2025 | Opzelura |
| Journey Medical Corporation | $145.89 | 2025 | |
| Organon LLC | $144.43 | 2025 | Vtama |
| Novartis Pharmaceuticals Corporation | $129.92 | 2025 | |
| Sanofi-Aventis U.S. LLC | $92.00 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $56.37 | 2025 | Anzupgo, Adbry |
| Lilly USA, LLC | $43.04 | 2025 | Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $40.49 | 2025 | Sotyktu |
| Pfizer INC. | $34.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Gaffney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.